Work

Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023–2024

Year: 2025

Type: article

Abstract: Projections for the US 2023-24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022-23, depending on circulating variants and vaccination uptake. The projections captured the tripledemic peak but missed the multiwave seasonality of COVID-19.

Source: Emerging infectious diseases

DOI: 10.3201/eid3103.240594

Authors: Kaiming Bi, Shraddha Ramdas Bandekar, Anass Bouchnita, Spencer J. Fox, Lauren Ancel Meyers

Language: English

Topic: Respiratory viral infections research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: Centers for Disease Control and Prevention, National Institute of Allergy and Infectious Diseases

Awards: MODELING TOOLKIT TO EVALUATE MULTIFACETED CONTROL STRATEGIES FOR SEASONAL AND PANDEMIC INFLUENZA, Accelerating viral outbreak detection in US cities using mechanistic models, machine learning and diverse geospatial data